SCHEMBL22945689

SCHEMBL22945689

c1ccc(-c2nc(-c3ccccc3)nc(N3c4c(ccc5ccccc45)-c4cccc5cccc3c45)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.43
ALDH1A1 P00352 5/20 0.40
HSD17B10 Q99714 4/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MAPK1 P28482 3/20 0.40
TSHR P16473 3/20 0.40
HPGD P15428 3/20 0.40
ATM Q13315 2/20 0.40
KDM4E B2RXH2 2/20 0.40
TP53 P04637 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.37
NPC1 O15118 2/20 0.35
LMNA P02545 2/20 0.35
RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26736890 0.90 PDE6D (0.38) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945075 0.89 PDE6D (0.36) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945585 0.88 PDE6D (0.35) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945134 0.88 PDE6D (0.41) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945076 0.87 PDE6D (0.37) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945077 0.87 ALOX5 (0.35) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945074 0.87 PDE6D (0.37) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945582 0.87 PDE6D (0.34) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945125 0.86 PDE6D (0.38) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL22945271 0.86 PDE6D (0.36) PDE6DALDH1A1HSD17B10MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812658-B2 Compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2023-11-07 US disclosed
US-11812658-B2 Compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2023-11-07 US disclosed
US-20210036236-A1 COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036236-A1 COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME DRD1, DRD3, DRD2 PDE6D 342/4885ALDH1A1 271/4885HSD17B10 1212/4885
US-11812658-B2 Compound and organic light emitting diode comprising same DRD1, DRD3, DRD2 PDE6D 342/4885ALDH1A1 271/4885HSD17B10 1212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.